Recombinant Escherichia coli Lipid A export ATP-binding/permease protein MsbA (msbA)

What is MsbA and what is its primary function in E. coli?

MsbA is an essential 65 kDa membrane protein belonging to the ABC (ATP-binding-cassette) superfamily in Gram-negative bacteria. It functions primarily as a homodimeric ATP-dependent lipid translocase or flippase that transports lipid A from the inner to the outer leaflet of the cytoplasmic membrane. This transport function is critical for the assembly of the outer membrane, as lipid A serves as the hydrophobic anchor for lipopolysaccharide (LPS) in the outer leaflet of the outer membrane. The essential nature of MsbA is likely due to its role in mediating this crucial step in LPS biogenesis .

How is MsbA structurally organized in the bacterial membrane?

MsbA exists as a homodimer embedded in the inner membrane of E. coli, with each monomer containing six transmembrane helices and a cytosolic ATP-binding domain. This structural organization is typical of ABC transporters, with the transmembrane domains forming the translocation pathway and the nucleotide-binding domains providing the energy for transport through ATP hydrolysis. Crystal structures of MsbA have been obtained, making it the first ABC efflux system for which high-resolution structures became available . The transmembrane domains are arranged to create a central cavity that accommodates various lipid substrates, while conformational changes driven by ATP binding and hydrolysis facilitate the translocation process.

What evidence supports MsbA's role in lipid A transport?

Multiple lines of evidence support MsbA's role in lipid A transport. First, mutations in MsbA result in cytoplasmic membrane accumulation of lipopolysaccharides, lipid A, and its derivatives. Second, in cells expressing missense MsbA mutants, phosphatidylethanolamine (PE) and lipid A are accessible from the cytoplasmic face of the membrane rather than the periplasmic face, consistent with a block in translocation. Third, temperature-sensitive MsbA mutants like WD2 (with the A270T substitution) synthesize hexa-acylated lipid A at non-permissive temperatures, but these molecules accumulate on the inner surface of the inner membrane, as demonstrated by their inaccessibility to modification enzymes like LpxE . Collectively, these findings provide strong evidence that MsbA functions in translocating lipid A across the inner membrane.

Does MsbA exclusively transport lipid A, or does it have broader substrate specificity?

Research demonstrates that MsbA has broader substrate specificity beyond lipid A. Purified and functionally active MsbA reconstituted into proteoliposomes displays flippase activity for various fluorescently NBD-labelled phospholipid species, including both headgroup- and acyl chain-labelled derivatives of phosphatidylethanolamine (PE) and phosphatidylserine (PS), as well as chain-labelled phosphatidylglycerol (PG), phosphatidylcholine (PC), and sphingomyelin (SM) . Additionally, MsbA has been shown to interact with multiple drugs. When expressed in Lactococcus lactis (which lacks LPS), MsbA conferred an 86-fold increase in resistance to the macrolide erythromycin and demonstrated transport activity for ethidium and Hoechst 33342 . These findings indicate that MsbA has a broader substrate specificity than initially thought, functioning both as a lipid translocase and potentially as a multidrug transporter.

How is MsbA's ATPase activity regulated by lipid interactions?

MsbA's ATPase activity is modulated by various lipids and lipid-based molecules. Direct binding studies using intrinsic tryptophan fluorescence quenching have shown that MsbA binds to lipid A, LPS precursors (RaLPS and ReLPS), and phospholipid-based amphipathic drugs with affinities in the low micromolar range . These interactions affect the protein's ATPase activity, suggesting a regulatory mechanism tied to substrate binding. The highest rates of flippase activity are observed when MsbA is reconstituted into an E. coli lipid mixture, indicating that the native lipid environment optimizes the protein's function . Additionally, free lipid A demonstrates noncompetitive inhibition of Hoechst 33342 transport with a Ki of 57 μM, in a similar range as the Ki for vinblastine (a known inhibitor), suggesting specific regulatory interactions between lipid A and MsbA that impact its transport activities .

What is the relationship between MsbA and other components of the LPS transport pathway?

MsbA represents the first step in the multi-component LPS transport pathway. After MsbA flips core-lipid A to the outer leaflet of the inner membrane, additional proteins facilitate its transport to the outer membrane. These include the periplasmic protein LptA, the cytosolic protein LptB, and the inner membrane proteins LptC, LptF, and LptG, which constitute a second ABC transporter complex with accessory proteins. At the outer membrane, the LptD/LptE complex ultimately flips LPS to the outer surface . Temperature-sensitive mutants of LptA (like MB1 with S22C and Q111P substitutions) show defective LPS export, with core-lipid A reaching the periplasmic side of the inner membrane but not the outer surface of the outer membrane at non-permissive temperatures . This indicates that MsbA functions specifically in the inner membrane flipping step, while the subsequent transport across the periplasm and to the outer membrane requires the coordinated action of the Lpt proteins.

How can functional MsbA be purified and reconstituted for in vitro studies?

For functional studies of MsbA, researchers typically express His6-tagged wild-type MsbA in E. coli, followed by purification and reconstitution into proteoliposomes. A successful reconstitution system involves the following methodology:

• Overexpression of His6-tagged MsbA in E. coli

• Membrane isolation and solubilization using appropriate detergents

• Affinity purification of the tagged protein

• Reconstitution into proteoliposomes composed of E. coli lipids (optimal) or other defined lipid mixtures

The functionality of reconstituted MsbA can be assessed through ATPase activity measurements and lipid translocation assays. The protein shows the highest rates of flippase activity when reconstituted into an E. coli lipid mixture, suggesting that the native lipid environment is important for optimal function . Importantly, the lipid-to-protein ratio is critical, as previous studies failed to demonstrate MsbA-mediated phospholipid flipping at a ratio of E. coli lipid/MsbA of approximately 10:1 (w/w) . This highlights the importance of reconstitution conditions in preserving MsbA's functional properties.

What assays can be used to measure MsbA-mediated lipid translocation?

Several complementary assays have been developed to measure MsbA-mediated lipid translocation:

• Fluorescent NBD-labeled lipid assays: This approach uses fluorescently NBD (7-nitrobenz-2-oxa-1,3-diazole)-labeled lipid species. After reconstitution of MsbA with these fluorescent lipids, translocation can be monitored by measuring changes in fluorescence intensity or by using dithionite quenching to distinguish between lipids in the inner and outer leaflets of the membrane .

• Enzymatic modification assays: This approach leverages enzymes that modify specific positions on lipid A. For example, LpxE (lipid A 1-phosphatase) can be used as a periplasmic inner membrane marker, while PagL (lipid A 3-O-deacylase) serves as an outer membrane marker. The accessibility of these enzymes to their respective substrates indicates the orientation and localization of lipid A .

• Drug transport assays: For studying MsbA's interaction with drugs, researchers have measured the transport of fluorescent substrates like ethidium and Hoechst 33342. These assays can reveal kinetic parameters and allow the characterization of inhibitors through competition studies .

• ATP hydrolysis assays: Since MsbA is an ATP-dependent transporter, measuring ATP hydrolysis rates in the presence of different lipids or drugs can provide insights into substrate interactions and transport mechanisms .

How can genetic approaches be used to study MsbA function in vivo?

Genetic approaches offer powerful tools for studying MsbA function in vivo:

• Temperature-sensitive mutants: Mutants like WD2 (with the A270T substitution in MsbA) allow controlled inactivation of the protein by temperature shifts. These mutants synthesize hexa-acylated lipid A at non-permissive temperatures, but the molecules accumulate on the inner surface of the inner membrane .

• Heterologous expression systems: Expressing MsbA in organisms like Lactococcus lactis, which lacks LPS, enables the study of MsbA's drug transport functions in an environment deficient in its native lipid A substrate. This approach revealed MsbA's ability to confer resistance to erythromycin and transport various drugs, supporting its multidrug transporter capabilities .

• Complementation studies: The essential nature of MsbA makes direct gene knockout challenging. Instead, researchers can replace the chromosomal gene with a cassette while providing a plasmid-encoded wild-type or mutant version in trans. This approach has been successfully used to study LptA and LptB mutants and could be applied to MsbA .

• Conditional expression systems: Placing MsbA under the control of inducible promoters allows for controlled depletion studies, revealing the consequences of MsbA deficiency over time.

What temperature-sensitive MsbA mutants have been characterized, and how do they affect lipid transport?

The WD2 mutant, harboring the A270T substitution in MsbA, is a well-characterized temperature-sensitive mutant. At non-permissive temperatures (42°C), WD2 continues to synthesize hexa-acylated lipid A for approximately 1 hour, but these molecules accumulate on the inner surface of the inner membrane. This accumulation is evidenced by the inaccessibility of lipid A to modification enzymes like LpxE, which acts on the periplasmic side of the inner membrane . The temperature-sensitive phenotype allows researchers to precisely control MsbA function through temperature shifts, providing a valuable tool for studying the consequences of MsbA inactivation without the need for gene deletion, which would be lethal due to MsbA's essential nature.

How do mutations in MsbA affect drug resistance in bacteria?

Mutations in MsbA can significantly impact drug resistance in bacteria. When wild-type MsbA from E. coli was expressed in Lactococcus lactis, it conferred an 86-fold increase in resistance to the macrolide erythromycin, demonstrating MsbA's ability to function as a multidrug transporter . The kinetic characterization of MsbA-mediated ethidium and Hoechst 33342 transport revealed apparent single-site kinetics and competitive inhibition by vinblastine with Ki values of 16 and 11 μM, respectively . These findings suggest that specific mutations in MsbA could potentially alter drug binding sites or transport efficiency, thereby modifying bacterial resistance to various antimicrobials. Understanding these structure-function relationships could inform strategies to overcome antibiotic resistance or develop inhibitors targeting MsbA.

What insights have been gained from studying MsbA structure through crystallography?

MsbA was the first ABC efflux system for which high-resolution crystal structures were obtained, providing crucial insights into its mechanism of action . The crystal structure of MsbA from Salmonella enterica serovar Typhimurium revealed direct LPS-MsbA interactions, supporting the functional data indicating MsbA's role in LPS transport . These structural studies have shown that MsbA forms a homodimer with each monomer containing six transmembrane helices and a cytosolic ATP-binding domain . The structural data have helped elucidate how conformational changes driven by ATP binding and hydrolysis facilitate substrate translocation across the membrane. Additionally, the structures provide a molecular framework for understanding how MsbA interacts with diverse substrates, including lipid A, phospholipids, and various drugs.

How does MsbA coordinate with other LPS transport machinery components?

While MsbA's role in flipping lipid A across the inner membrane is well-established, how it coordinates with other components of the LPS transport machinery remains an area of active investigation. After MsbA flips core-lipid A to the outer leaflet of the inner membrane, the LptA/B/C/F/G system facilitates its transport to the outer membrane, where the LptD/LptE complex ultimately flips LPS to the outer surface . Questions remain about how these systems communicate and coordinate their activities. Are there direct protein-protein interactions between MsbA and components of the Lpt system? Is there a signaling mechanism that ensures properly timed handoff of LPS from one system to the next? Additionally, the potential role of other accessory proteins in facilitating this coordination has not been fully explored. Future research using techniques like protein-protein interaction studies, co-immunoprecipitation, and high-resolution imaging could help elucidate these coordination mechanisms.

What are the implications of MsbA's dual role as a lipid transporter and multidrug transporter?

The discovery that MsbA can function both as a lipid transporter and as a multidrug transporter raises intriguing questions about its evolutionary history and physiological significance. Does this dual functionality reflect an ancient, broader substrate specificity that has been partially conserved? Or has MsbA evolved specifically to handle diverse substrates in response to environmental pressures? From a mechanistic perspective, how does MsbA accommodate such structurally diverse molecules within the same translocation pathway? Understanding these aspects could provide insights into the general principles of ABC transporter substrate recognition and transport.